CAS 928853-86-5

Formel: C16H19N5S

InChl: InChI=1S/C16H19N5S/c1-11-14-15(22-13-6-4-3-5-12(13)18-14)19-16(17-11)21-9-7-20(2)8-10-21/h3-6,18H,7-10H2,1-2H3

InChI Key: HYPHGMNLWIKEMB-UHFFFAOYSA-N

SMILES: CC1=C2C(=NC(=N1)N3CCN(CC3)C)SC4=CC=CC=C4N2

4-MMPB

CAS: 928853-86-5

4-MMPB

Formel: C₁₆H₁₉N₅S

Reinheit: 97%

Molekulargewicht: 313.42

Ref: 54-BUP02311

4-MMPB

CAS: 928853-86-5

Formel: C₁₆H₁₉N₅S

Reinheit: 98%

Molekulargewicht: 313.4206

Ref: IN-DA00GTAA

4-MMPB

CAS: 928853-86-5

15-Lipoxygenase Inhibitor 1 is a selective inhibitor of 15-lipoxygenase, with an IC50 of 18 μM.

Formel: C₁₆H₁₉N₅S

Reinheit: 97.18%

Farbe und Form: Solid

Molekulargewicht: 313.421

Ref: TM-T8794

4-Methyl-2-(4-methylpiperazinyl)pyrimido[4,5-b]benzothiazine

CAS: 928853-86-5

The inhibitory mechanism of 4-Methyl-2-(4-methylpiperazinyl) pyrimido[4,5-b]benzothiazine is not well understood. It has been shown to have anti-cancer effects in animals and humans, with a potency that is similar to that of the hydrogen bond inhibitor amsacrine. 4MPBTZD inhibits the activity of lipoxygenases, which are enzymes that produce reactive oxygen species (ROS). It also inhibits the activity of prenyl protein transferase (PPR), which is involved in lipid metabolism. The synthesis of 4MPBTZD involves two steps: first, a benzothiazole ring system is formed from an aromatic compound and dimethylaminopyridine; second, methylpiperazine is added to form a pyrimidopyrimidine ring system. This drug has potent inhibitory activity against ferroptosis and mechanistic studies show it may be due to its

Formel: C₁₆H₁₉N₅S

Reinheit: Min. 95%

Molekulargewicht: 313.4 g/mol

Ref: 3D-DMB85386